Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PRCT - PROCEPT BioRobotics Corporation
Market Cap 1.62B P/E - EPS this Y 16.10% Ern Qtrly Grth -
Income -103.71M Forward P/E -19.78 EPS next Y 22.30% 50D Avg Chg 3.00%
Sales 176.58M PEG -1.85 EPS past 5Y - 200D Avg Chg -2.00%
Dividend N/A Price/Book 10.45 EPS next 5Y 23.10% 52W High Chg -31.00%
Recommedations 1.70 Quick Ratio 6.37 Shares Outstanding 51.93M 52W Low Chg 42.00%
Insider Own 4.94% ROA -21.19% Shares Float 49.58M Beta 1.03
Inst Own 88.07% ROE -50.88% Shares Shorted/Prior 5.70M/5.67M Price 36.00
Gross Margin 54.73% Profit Margin -58.73% Avg. Volume 475,209 Target Price 88.50
Oper. Margin -50.28% Earnings Date Oct 30 Volume 2,014,766 Change 6.13%
Healthcare | Medical Devices | United States
About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PROCEPT BioRobotics Corporation News
11/29/24 PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance
04:05 PM PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
11/07/24 Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice
11/01/24 These IBD 50 Leaders Melt Gains As Stock Market Wavers
10/29/24 PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
10/29/24 All You Need to Know About PROCEPT BioRobotics (PRCT) Rating Upgrade to Strong Buy
10/29/24 Medical Gear Stock Surges Past Buy Point On Upbeat Sales Outlook
10/29/24 Stock Market News for Oct 29, 2024
10/29/24 PROCEPT BioRobotics Third Quarter 2024 Earnings: Beats Expectations
10/29/24 PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
10/28/24 Procept BioRobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise
10/28/24 PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
10/28/24 Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential
10/28/24 PROCEPT BioRobotics Jumps 30% Today on Massive Revenue Surge
10/28/24 PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates
10/28/24 Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner
10/28/24 PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
10/25/24 Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround
10/24/24 Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline
10/21/24 PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Jan 09 Sell 44.97 16,000 719,520 47,351 01/11/24
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Jan 09 Option 4.56 16,000 72,960 63,351 01/11/24
Waters Kevin EVP, CFO EVP, CFO Jan 09 Sell 45.07 17,310 780,162 33,523 01/11/24
Waters Kevin EVP, CFO EVP, CFO Jan 09 Option 4.52 17,310 78,241 50,833 01/11/24
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Dec 14 Sell 42.96 15,000 644,400 46,933 12/15/23
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Dec 14 Option 4.56 15,000 68,400 58,729 12/15/23
Waters Kevin EVP, CFO EVP, CFO Dec 13 Sell 40.05 71,465 2,862,173 33,523 12/15/23
Waters Kevin EVP, CFO EVP, CFO Dec 13 Option 4.52 71,465 323,022 104,988 12/15/23
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Dec 06 Sell 39.96 6,096 243,596 46,933 12/08/23
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Dec 06 Option 4.52 6,096 27,554 53,029 12/08/23
Waters Kevin EVP, CFO EVP, CFO Dec 06 Sell 40.01 15,085 603,551 33,523 12/08/23
Waters Kevin EVP, CFO EVP, CFO Dec 06 Option 4.52 15,085 68,184 48,608 12/08/23
MOLL FREDERIC H Director Director Dec 06 Sell 38.87 79,000 3,070,730 808,233 12/08/23
Wood Morgan Colby Director Director Nov 13 Sell 32.1924 25,000 804,810 112,425 11/14/23
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Jul 27 Sell 40 7,903 316,120 46,933 07/31/23
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Jul 27 Option 4.52 7,903 35,722 54,836 07/31/23
Waters Kevin EVP, CFO EVP, CFO Jun 15 Sell 35.1249 22,631 794,912 33,523 06/15/23
Zadno Reza President, CEO President, CEO Apr 28 Option 4.37 19,995 87,378 195,808 05/02/23
Zadno Reza President, CEO President, CEO Apr 04 Option 4.37 20,022 87,496 175,813 04/05/23
Waters Kevin EVP, CFO EVP, CFO Mar 07 Sell 34.56 30,000 1,036,800 56,860 03/09/23
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. Mar 08 Option 4.52 10,000 45,200 35,114 03/09/23
Krummel Thomas M Director Director Jun 21 Option 3.45 20,000 69,000 102,920 06/22/22
Krummel Thomas M Director Director Jun 21 Sell 35.76 20,000 715,200 82,920 06/22/22
Nouri Alaleh EVP, CLO, CORP. SEC. EVP, CLO, CORP. SEC. May 16 Sell 35.06 678 23,771 46,468 05/16/22
VIKING GLOBAL INVESTORS LP 10% Owner 10% Owner Mar 18 Sell 29.9 1,249,000 37,345,100 298,205 03/22/22
Wood Morgan Colby Director Director Mar 11 Buy 24.4262 940 22,961 147,713 03/14/22